Plaintiffs across the country claim the drugs caused severe gastrointestinal complications, including stomach paralysis, chronic vomiting and intestinal obstruction
Summary: Retatrutide is taken once weekly as a subcutaneous injection, with doses gradually escalated from a low starting dose up to a studied maximum of 12 mg in Phase 2 trials, though it is not yet approved for use in the UK
These tablets should be taken on an empty stomach at least 30 minutes before eating or drinking
If you cannot generate that data, revise the claim to something that is defensible without it
Additionally, if itching is severe enough to disrupt sleep, daily activities, or quality of life, or if it is associated with skin changes such as blistering, peeling, or significant inflammation, medical review is advisable
This is good news without a doubt